triazoles has been researched along with tozadenant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alagille, D; Barret, O; Fowles, K; Hannestad, J; Laruelle, M; Lee, H; Morley, T; Papin, C; Seibyl, J; Tamagnan, G; Tavares, A; Tytgat, D; Vala, C | 1 |
| Downey, P; Michel, A; Nicolas, JM; Scheller, D | 1 |
| Jeong, BC; Kim, JW; Koh, JT; Kook, MS; Lee, MN; Oh, SH | 1 |
3 other study(ies) available for triazoles and tozadenant
| Article | Year |
|---|---|
Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys.
Topics: Animals; Benzothiazoles; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Heterocyclic Compounds, 3-Ring; Humans; Macaca mulatta; Parkinson Disease; Positron-Emission Tomography; Pyrimidines; Radiometry; Receptor, Adenosine A2A; Time Factors; Triazoles; Whole Body Imaging | 2014 |
Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's disease.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Benzothiazoles; Drug Therapy, Combination; Levodopa; Mass Spectrometry; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Piperidines; Purines; Pyrimidines; Rats; Receptors, N-Methyl-D-Aspartate; Triazoles | 2014 |
Chemical inhibitors of c-Met receptor tyrosine kinase stimulate osteoblast differentiation and bone regeneration.
Topics: 3T3-L1 Cells; Animals; Benzothiazoles; Bone Regeneration; Calcification, Physiologic; Cell Differentiation; Core Binding Factor Alpha 1 Subunit; Male; Mice; Mice, Inbred C57BL; Osteoblasts; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyridazines; Skull; Triazoles | 2017 |